

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process (GO:1902222) | 5.80220017 |
| 2 | L-phenylalanine catabolic process (GO:0006559) | 5.80220017 |
| 3 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process (GO:1902221) | 5.77811231 |
| 4 | L-phenylalanine metabolic process (GO:0006558) | 5.77811231 |
| 5 | aromatic amino acid family catabolic process (GO:0009074) | 5.34356932 |
| 6 | synaptic vesicle maturation (GO:0016188) | 5.10143694 |
| 7 | indole-containing compound catabolic process (GO:0042436) | 4.99613835 |
| 8 | indolalkylamine catabolic process (GO:0046218) | 4.99613835 |
| 9 | tryptophan catabolic process (GO:0006569) | 4.99613835 |
| 10 | glutamate secretion (GO:0014047) | 4.93202466 |
| 11 | synaptic vesicle exocytosis (GO:0016079) | 4.88953777 |
| 12 | tryptophan metabolic process (GO:0006568) | 4.82741437 |
| 13 | kynurenine metabolic process (GO:0070189) | 4.82065695 |
| 14 | cysteine metabolic process (GO:0006534) | 4.77884879 |
| 15 | alpha-linolenic acid metabolic process (GO:0036109) | 4.72835147 |
| 16 | triglyceride-rich lipoprotein particle remodeling (GO:0034370) | 4.70979854 |
| 17 | urea cycle (GO:0000050) | 4.65007253 |
| 18 | urea metabolic process (GO:0019627) | 4.65007253 |
| 19 | sulfur amino acid catabolic process (GO:0000098) | 4.64314019 |
| 20 | bile acid biosynthetic process (GO:0006699) | 4.50497927 |
| 21 | glyoxylate metabolic process (GO:0046487) | 4.43135362 |
| 22 | complement activation, alternative pathway (GO:0006957) | 4.34089339 |
| 23 | high-density lipoprotein particle remodeling (GO:0034375) | 4.33077054 |
| 24 | regulation of short-term neuronal synaptic plasticity (GO:0048172) | 4.31140601 |
| 25 | regulation of protein activation cascade (GO:2000257) | 4.30996728 |
| 26 | valine metabolic process (GO:0006573) | 4.29796557 |
| 27 | fatty acid beta-oxidation using acyl-CoA oxidase (GO:0033540) | 4.28644209 |
| 28 | synaptic vesicle docking involved in exocytosis (GO:0016081) | 4.25859779 |
| 29 | nitrogen cycle metabolic process (GO:0071941) | 4.25350894 |
| 30 | regulation of synaptic vesicle exocytosis (GO:2000300) | 4.23774724 |
| 31 | serine family amino acid catabolic process (GO:0009071) | 4.19745455 |
| 32 | lysine catabolic process (GO:0006554) | 4.18575728 |
| 33 | lysine metabolic process (GO:0006553) | 4.18575728 |
| 34 | amino-acid betaine metabolic process (GO:0006577) | 4.18526360 |
| 35 | gamma-aminobutyric acid transport (GO:0015812) | 4.17956553 |
| 36 | protein carboxylation (GO:0018214) | 4.13837332 |
| 37 | peptidyl-glutamic acid carboxylation (GO:0017187) | 4.13837332 |
| 38 | regulation of complement activation (GO:0030449) | 4.09887134 |
| 39 | aldehyde catabolic process (GO:0046185) | 4.08729949 |
| 40 | negative regulation of fibrinolysis (GO:0051918) | 4.06164544 |
| 41 | homocysteine metabolic process (GO:0050667) | 4.05408822 |
| 42 | aromatic amino acid family metabolic process (GO:0009072) | 4.00169597 |
| 43 | sodium ion export (GO:0071436) | 3.91427635 |
| 44 | ethanol oxidation (GO:0006069) | 3.88148270 |
| 45 | reverse cholesterol transport (GO:0043691) | 3.87846581 |
| 46 | cellular glucuronidation (GO:0052695) | 3.87802913 |
| 47 | membrane depolarization during cardiac muscle cell action potential (GO:0086012) | 3.86765353 |
| 48 | neurotransmitter secretion (GO:0007269) | 3.85714624 |
| 49 | regulation of triglyceride catabolic process (GO:0010896) | 3.85283407 |
| 50 | cellular potassium ion homeostasis (GO:0030007) | 3.84164451 |
| 51 | tyrosine metabolic process (GO:0006570) | 3.82584605 |
| 52 | positive regulation of calcium ion-dependent exocytosis (GO:0045956) | 3.81433435 |
| 53 | bile acid metabolic process (GO:0008206) | 3.78876255 |
| 54 | positive regulation of excitatory postsynaptic membrane potential (GO:2000463) | 3.76919460 |
| 55 | glycine metabolic process (GO:0006544) | 3.74778416 |
| 56 | vocalization behavior (GO:0071625) | 3.73680520 |
| 57 | plasma lipoprotein particle remodeling (GO:0034369) | 3.73126685 |
| 58 | protein-lipid complex remodeling (GO:0034368) | 3.73126685 |
| 59 | macromolecular complex remodeling (GO:0034367) | 3.73126685 |
| 60 | regulation of fibrinolysis (GO:0051917) | 3.72107435 |
| 61 | alpha-amino acid catabolic process (GO:1901606) | 3.71660475 |
| 62 | negative regulation of cholesterol transport (GO:0032375) | 3.66464988 |
| 63 | negative regulation of sterol transport (GO:0032372) | 3.66464988 |
| 64 | regulation of cholesterol esterification (GO:0010872) | 3.64374908 |
| 65 | serine family amino acid metabolic process (GO:0009069) | 3.61124067 |
| 66 | L-amino acid import (GO:0043092) | 3.61060813 |
| 67 | benzene-containing compound metabolic process (GO:0042537) | 3.60400099 |
| 68 | glucuronate metabolic process (GO:0019585) | 3.58542611 |
| 69 | uronic acid metabolic process (GO:0006063) | 3.58542611 |
| 70 | neuron cell-cell adhesion (GO:0007158) | 3.56766802 |
| 71 | amino acid import (GO:0043090) | 3.56147795 |
| 72 | phospholipid efflux (GO:0033700) | 3.55148290 |
| 73 | regulation of synaptic vesicle transport (GO:1902803) | 3.54885721 |
| 74 | pyrimidine nucleobase catabolic process (GO:0006208) | 3.52640924 |
| 75 | cell communication by electrical coupling involved in cardiac conduction (GO:0086064) | 3.48780972 |
| 76 | plasma lipoprotein particle clearance (GO:0034381) | 3.48532146 |
| 77 | indolalkylamine metabolic process (GO:0006586) | 3.47009108 |
| 78 | cellular amino acid catabolic process (GO:0009063) | 3.46713367 |
| 79 | serine family amino acid biosynthetic process (GO:0009070) | 3.43695869 |
| 80 | drug catabolic process (GO:0042737) | 3.43514700 |
| 81 | bile acid and bile salt transport (GO:0015721) | 3.41577220 |
| 82 | regulation of synapse structural plasticity (GO:0051823) | 3.37276713 |
| 83 | acylglycerol homeostasis (GO:0055090) | 3.32145733 |
| 84 | triglyceride homeostasis (GO:0070328) | 3.32145733 |
| 85 | 2-oxoglutarate metabolic process (GO:0006103) | 3.31775586 |
| 86 | ionotropic glutamate receptor signaling pathway (GO:0035235) | 3.31639517 |
| 87 | urate metabolic process (GO:0046415) | 3.28676134 |
| 88 | pyridine nucleotide biosynthetic process (GO:0019363) | 3.27361801 |
| 89 | nicotinamide nucleotide biosynthetic process (GO:0019359) | 3.27361801 |
| 90 | carnitine metabolic process (GO:0009437) | 3.27161645 |
| 91 | complement activation, classical pathway (GO:0006958) | 3.26191169 |
| 92 | amine catabolic process (GO:0009310) | 3.26145190 |
| 93 | cellular biogenic amine catabolic process (GO:0042402) | 3.26145190 |
| 94 | arginine metabolic process (GO:0006525) | 3.23632481 |
| 95 | cholesterol efflux (GO:0033344) | 3.21857531 |
| 96 | fatty acid oxidation (GO:0019395) | 3.21727267 |
| 97 | folic acid metabolic process (GO:0046655) | 3.21305375 |
| 98 | cellular modified amino acid catabolic process (GO:0042219) | 3.20450920 |
| 99 | carboxylic acid catabolic process (GO:0046395) | 3.20361663 |
| 100 | organic acid catabolic process (GO:0016054) | 3.20361663 |
| 101 | fatty acid beta-oxidation (GO:0006635) | 3.19697305 |
| 102 | complement activation (GO:0006956) | 3.19566617 |
| 103 | xenobiotic catabolic process (GO:0042178) | 3.19133512 |
| 104 | NAD biosynthetic process (GO:0009435) | 3.18114743 |
| 105 | imidazole-containing compound metabolic process (GO:0052803) | 3.16625747 |
| 106 | lipid oxidation (GO:0034440) | 3.16432475 |
| 107 | cell communication by electrical coupling (GO:0010644) | 3.14401001 |
| 108 | oxaloacetate metabolic process (GO:0006107) | 3.13037026 |
| 109 | axonal fasciculation (GO:0007413) | 3.12932727 |
| 110 | neuronal ion channel clustering (GO:0045161) | 3.12629208 |
| 111 | detection of calcium ion (GO:0005513) | 3.11610510 |
| 112 | cofactor catabolic process (GO:0051187) | 3.10672961 |
| 113 | low-density lipoprotein particle remodeling (GO:0034374) | 3.10141066 |
| 114 | monocarboxylic acid catabolic process (GO:0072329) | 3.08989622 |
| 115 | pantothenate metabolic process (GO:0015939) | 3.08980716 |
| 116 | negative regulation of protein activation cascade (GO:2000258) | 3.08747630 |
| 117 | cerebellar granule cell differentiation (GO:0021707) | 3.08145238 |
| 118 | short-chain fatty acid metabolic process (GO:0046459) | 3.06636821 |
| 119 | negative regulation of synaptic transmission, GABAergic (GO:0032229) | 3.06380057 |
| 120 | neuron recognition (GO:0008038) | 3.06075622 |
| 121 | S-adenosylmethionine metabolic process (GO:0046500) | 3.05181088 |
| 122 | fructose metabolic process (GO:0006000) | 3.04611617 |
| 123 | regulation of neuronal synaptic plasticity (GO:0048168) | 3.04246413 |
| 124 | synaptic transmission, glutamatergic (GO:0035249) | 3.03858215 |
| 125 | fatty acid catabolic process (GO:0009062) | 3.02582730 |
| 126 | dendritic spine organization (GO:0097061) | 3.02547016 |
| 127 | acute-phase response (GO:0006953) | 3.01985711 |
| 128 | folic acid transport (GO:0015884) | 3.01578183 |
| 129 | plasma lipoprotein particle assembly (GO:0034377) | 3.00852938 |
| 130 | coenzyme catabolic process (GO:0009109) | 3.00750220 |
| 131 | response to nitrosative stress (GO:0051409) | 3.00708272 |
| 132 | dendritic spine morphogenesis (GO:0060997) | 3.00095199 |
| 133 | fibrinolysis (GO:0042730) | 2.99865381 |
| 134 | presynaptic membrane organization (GO:0097090) | 2.99569647 |
| 135 | postsynaptic membrane organization (GO:0001941) | 2.99095508 |
| 136 | presynaptic membrane assembly (GO:0097105) | 2.98752718 |
| 137 | locomotory exploration behavior (GO:0035641) | 2.97473489 |
| 138 | regulation of neurotransmitter secretion (GO:0046928) | 2.97236716 |
| 139 | protein localization to synapse (GO:0035418) | 2.96590595 |
| 140 | nucleobase catabolic process (GO:0046113) | 2.95591489 |
| 141 | glycine transport (GO:0015816) | 2.94197858 |
| 142 | neurotransmitter transport (GO:0006836) | 2.94191178 |
| 143 | cellular sodium ion homeostasis (GO:0006883) | 2.93942491 |
| 144 | layer formation in cerebral cortex (GO:0021819) | 2.90903204 |
| 145 | regulation of neurotransmitter levels (GO:0001505) | 2.88745399 |
| 146 | neuron-neuron synaptic transmission (GO:0007270) | 2.88118840 |
| 147 | regulation of dendritic spine morphogenesis (GO:0061001) | 2.88047760 |
| 148 | neurotransmitter-gated ion channel clustering (GO:0072578) | 2.86755899 |
| 149 | positive regulation of dendritic spine development (GO:0060999) | 2.85639037 |
| 150 | glutamate receptor signaling pathway (GO:0007215) | 2.80440211 |
| 151 | regulation of dendritic spine development (GO:0060998) | 2.78916658 |
| 152 | cell communication involved in cardiac conduction (GO:0086065) | 2.78876390 |
| 153 | regulation of vesicle fusion (GO:0031338) | 2.78689801 |
| 154 | neurofilament cytoskeleton organization (GO:0060052) | 2.72670680 |
| 155 | regulation of neurotransmitter transport (GO:0051588) | 2.69444652 |
| 156 | positive regulation of membrane potential (GO:0045838) | 2.67554169 |
| 157 | synaptic vesicle endocytosis (GO:0048488) | 2.63880269 |
| 158 | regulation of excitatory postsynaptic membrane potential (GO:0060079) | 2.61951669 |
| 159 | potassium ion homeostasis (GO:0055075) | 2.61211767 |
| 160 | regulation of long-term neuronal synaptic plasticity (GO:0048169) | 2.61112748 |
| 161 | positive regulation of potassium ion transmembrane transporter activity (GO:1901018) | 2.60984726 |
| 162 | regulation of alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate selective glutamate receptor act | 2.59825550 |
| 163 | regulation of synaptic plasticity (GO:0048167) | 2.59795562 |
| 164 | cell migration in hindbrain (GO:0021535) | 2.59760038 |
| 165 | auditory behavior (GO:0031223) | 2.59246700 |
| 166 | negative regulation of dendrite development (GO:2000171) | 2.58943286 |
| 167 | regulation of respiratory gaseous exchange by neurological system process (GO:0002087) | 2.58403877 |
| 168 | exploration behavior (GO:0035640) | 2.58061505 |
| 169 | synapse assembly (GO:0007416) | 2.57733682 |
| 170 | positive regulation of synapse maturation (GO:0090129) | 2.57262774 |
| 171 | apical protein localization (GO:0045176) | 2.55992564 |
| 172 | neuronal action potential propagation (GO:0019227) | 2.55796603 |
| 173 | regulation of cardiac muscle contraction by calcium ion signaling (GO:0010882) | 2.55595345 |
| 174 | regulation of ARF protein signal transduction (GO:0032012) | 2.54552303 |
| 175 | suckling behavior (GO:0001967) | 2.53148075 |
| 176 | regulation of postsynaptic membrane potential (GO:0060078) | 2.53079035 |
| 177 | establishment of mitochondrion localization (GO:0051654) | 2.51345937 |
| 178 | regulation of N-methyl-D-aspartate selective glutamate receptor activity (GO:2000310) | 2.50706674 |
| 179 | vesicle transport along microtubule (GO:0047496) | 2.50623790 |
| 180 | regulation of cardiac muscle contraction by regulation of the release of sequestered calcium ion (GO | 2.48131968 |
| 181 | regulation of cell communication by electrical coupling (GO:0010649) | 2.46887322 |
| 182 | synaptic vesicle transport (GO:0048489) | 2.45660702 |
| 183 | establishment of synaptic vesicle localization (GO:0097480) | 2.45660702 |
| 184 | regulation of clathrin-mediated endocytosis (GO:2000369) | 2.45303317 |
| 185 | central nervous system projection neuron axonogenesis (GO:0021952) | 2.45169903 |
| 186 | membrane depolarization during action potential (GO:0086010) | 2.44508286 |
| 187 | regulation of voltage-gated calcium channel activity (GO:1901385) | 2.43739704 |
| 188 | proline transport (GO:0015824) | 2.42629959 |
| 189 | regulation of glutamate receptor signaling pathway (GO:1900449) | 2.42374823 |
| 190 | negative regulation of dendrite morphogenesis (GO:0050774) | 2.42076421 |
| 191 | short-term memory (GO:0007614) | 2.40938338 |
| 192 | glycosphingolipid biosynthetic process (GO:0006688) | 2.40456241 |
| 193 | long-term synaptic potentiation (GO:0060291) | 2.40267646 |
| 194 | establishment of vesicle localization (GO:0051650) | 2.37407334 |
| 195 | calcium ion-dependent exocytosis (GO:0017156) | 2.36610789 |
| 196 | neuromuscular process controlling balance (GO:0050885) | 2.35288906 |
| 197 | organelle transport along microtubule (GO:0072384) | 2.34112623 |
| 198 | signal release (GO:0023061) | 2.33369730 |
| 199 | regulation of atrial cardiac muscle cell membrane depolarization (GO:0060371) | 2.31353774 |
| 200 | clathrin coat assembly (GO:0048268) | 2.31054489 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 8.34310071 |
| 2 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 5.75714225 |
| 3 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 5.23416973 |
| 4 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 5.02162317 |
| 5 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 4.54486298 |
| 6 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 4.31889351 |
| 7 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 4.11660158 |
| 8 | EZH2_22144423_ChIP-Seq_EOC_Human | 3.58666002 |
| 9 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 3.46121056 |
| 10 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 3.40938618 |
| 11 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 3.03782437 |
| 12 | GBX2_23144817_ChIP-Seq_PC3_Human | 2.99379487 |
| 13 | NR4A2_19515692_ChIP-ChIP_MN9D_Mouse | 2.82725376 |
| 14 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 2.50531502 |
| 15 | SUZ12_18692474_ChIP-Seq_MESCs_Mouse | 2.36408361 |
| 16 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 2.25340893 |
| 17 | ZFP322A_24550733_ChIP-Seq_MESCs_Mouse | 2.15807018 |
| 18 | SUZ12_18555785_ChIP-Seq_MESCs_Mouse | 2.14434990 |
| 19 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 2.11812986 |
| 20 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 2.10197990 |
| 21 | ZFP57_27257070_Chip-Seq_ESCs_Mouse | 2.08140536 |
| 22 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 2.07647731 |
| 23 | JARID2_20064375_ChIP-Seq_MESCs_Mouse | 2.07465123 |
| 24 | EZH2_27304074_Chip-Seq_ESCs_Mouse | 2.07035478 |
| 25 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 2.05749971 |
| 26 | HNF4A_19761587_ChIP-ChIP_CACO-2_Human | 2.02291398 |
| 27 | REST_21632747_ChIP-Seq_MESCs_Mouse | 2.00936756 |
| 28 | EED_16625203_ChIP-ChIP_MESCs_Mouse | 1.98787480 |
| 29 | JARID2_20075857_ChIP-Seq_MESCs_Mouse | 1.98053412 |
| 30 | SUZ12_18974828_ChIP-Seq_MESCs_Mouse | 1.92064502 |
| 31 | EZH2_18974828_ChIP-Seq_MESCs_Mouse | 1.91911119 |
| 32 | RNF2_18974828_ChIP-Seq_MESCs_Mouse | 1.91911119 |
| 33 | SUZ12_18692474_ChIP-Seq_MEFs_Mouse | 1.90517823 |
| 34 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 1.90303067 |
| 35 | SUZ12_16625203_ChIP-ChIP_MESCs_Mouse | 1.89006784 |
| 36 | GATA1_22025678_ChIP-Seq_K562_Human | 1.88374833 |
| 37 | SUZ12_20075857_ChIP-Seq_MESCs_Mouse | 1.87637782 |
| 38 | MTF2_20144788_ChIP-Seq_MESCs_Mouse | 1.86861130 |
| 39 | DROSHA_22980978_ChIP-Seq_HELA_Human | 1.84655803 |
| 40 | CEBPD_23245923_ChIP-Seq_MEFs_Mouse | 1.84493301 |
| 41 | TAF15_26573619_Chip-Seq_HEK293_Human | 1.84028425 |
| 42 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 1.83704255 |
| 43 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 1.79779972 |
| 44 | RNF2_27304074_Chip-Seq_ESCs_Mouse | 1.74086339 |
| 45 | IGF1R_20145208_ChIP-Seq_DFB_Human | 1.72878299 |
| 46 | EZH2_27294783_Chip-Seq_ESCs_Mouse | 1.71396025 |
| 47 | SMARCA4_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.70287668 |
| 48 | EKLF_21900194_ChIP-Seq_ERYTHROCYTE_Mouse | 1.70284458 |
| 49 | RARB_27405468_Chip-Seq_BRAIN_Mouse | 1.67479362 |
| 50 | SMAD4_21799915_ChIP-Seq_A2780_Human | 1.67474842 |
| 51 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 1.66125576 |
| 52 | CTBP2_25329375_ChIP-Seq_LNCAP_Human | 1.65670637 |
| 53 | CBX2_27304074_Chip-Seq_ESCs_Mouse | 1.64984321 |
| 54 | ZNF217_24962896_ChIP-Seq_MCF-7_Human | 1.63523520 |
| 55 | AR_22383394_ChIP-Seq_PROSTATE_CANCER_Human | 1.63041982 |
| 56 | REST_18959480_ChIP-ChIP_MESCs_Mouse | 1.62755291 |
| 57 | * IRF8_21731497_ChIP-ChIP_J774_Mouse | 1.61981912 |
| 58 | SUZ12_27294783_Chip-Seq_ESCs_Mouse | 1.61343976 |
| 59 | AR_21572438_ChIP-Seq_LNCaP_Human | 1.58015794 |
| 60 | SMARCD1_25818293_ChIP-Seq_ESCs_Mouse | 1.57794687 |
| 61 | CDKN2AIP_20523734_ChIP-Seq_CORTICAL_Neurons | 1.57458986 |
| 62 | PAX3-FKHR_20663909_ChIP-Seq_RHABDOMYOSARCOMA_Human | 1.54260350 |
| 63 | RBPJ_22232070_ChIP-Seq_NCS_Mouse | 1.52951281 |
| 64 | CLOCK_20551151_ChIP-Seq_293T_Human | 1.48223084 |
| 65 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 1.47312140 |
| 66 | * POU3F2_20337985_ChIP-ChIP_501MEL_Human | 1.45445320 |
| 67 | EP300_21415370_ChIP-Seq_HL-1_Mouse | 1.44380042 |
| 68 | TAL1_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.41529752 |
| 69 | OLIG2_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.40339190 |
| 70 | SMAD2/3_21741376_ChIP-Seq_EPCs_Human | 1.37985158 |
| 71 | SMAD3_21741376_ChIP-Seq_EPCs_Human | 1.37945249 |
| 72 | NR3C1_23031785_ChIP-Seq_PC12_Mouse | 1.37455335 |
| 73 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 1.33214967 |
| 74 | AR_25329375_ChIP-Seq_VCAP_Human | 1.33019137 |
| 75 | TCF7L2_21901280_ChIP-Seq_H4IIE_Rat | 1.32086524 |
| 76 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 1.30008102 |
| 77 | RNF2_27304074_Chip-Seq_NSC_Mouse | 1.29193322 |
| 78 | CTBP1_25329375_ChIP-Seq_LNCAP_Human | 1.28884272 |
| 79 | NRF2_20460467_ChIP-Seq_MEFs_Mouse | 1.26714829 |
| 80 | NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 1.26714829 |
| 81 | AR_21909140_ChIP-Seq_LNCAP_Human | 1.26516976 |
| 82 | CREB1_15753290_ChIP-ChIP_HEK293T_Human | 1.26420518 |
| 83 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 1.26179630 |
| 84 | P300_19829295_ChIP-Seq_ESCs_Human | 1.25637246 |
| 85 | ESR1_22446102_ChIP-Seq_UTERUS_Mouse | 1.24421653 |
| 86 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 1.23648527 |
| 87 | MEIS1_26253404_ChIP-Seq_OPTIC_CUPS_Mouse | 1.23441869 |
| 88 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 1.22791029 |
| 89 | RNF2_16625203_ChIP-ChIP_MESCs_Mouse | 1.22473535 |
| 90 | TCFCP2L1_18555785_Chip-Seq_ESCs_Mouse | 1.21572509 |
| 91 | PHC1_16625203_ChIP-ChIP_MESCs_Mouse | 1.21504908 |
| 92 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 1.21487712 |
| 93 | MEIS1_26923725_Chip-Seq_HEMOGENIC-ENDOTHELIUM_Mouse | 1.20749593 |
| 94 | * SRF_21415370_ChIP-Seq_HL-1_Mouse | 1.20364434 |
| 95 | NANOG_18555785_Chip-Seq_ESCs_Mouse | 1.19322217 |
| 96 | STAT3_23295773_ChIP-Seq_U87_Human | 1.18304191 |
| 97 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.17928987 |
| 98 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 1.17702399 |
| 99 | SOX2_21211035_ChIP-Seq_LN229_Gbm | 1.17518573 |
| 100 | GABP_17652178_ChIP-ChIP_JURKAT_Human | 1.17272246 |
| 101 | AHR_22903824_ChIP-Seq_MCF-7_Human | 1.17224599 |
| 102 | TOP2B_26459242_ChIP-Seq_MCF-7_Human | 1.16948763 |
| 103 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 1.15903978 |
| 104 | YAP1_20516196_ChIP-Seq_MESCs_Mouse | 1.14142241 |
| 105 | RING1B_27294783_Chip-Seq_ESCs_Mouse | 1.14051097 |
| 106 | ARNT_22903824_ChIP-Seq_MCF-7_Human | 1.13511416 |
| 107 | WT1_25993318_ChIP-Seq_PODOCYTE_Human | 1.13219483 |
| 108 | NR3C1_21868756_ChIP-Seq_MCF10A_Human | 1.12959504 |
| 109 | KDM6A_18722178_ChIP-ChIP_U937_AND_SAOS2_Human | 1.12779167 |
| 110 | TCF3/E2A_22897851_ChIP-Seq_JUKARTE6-1_Human | 1.12472716 |
| 111 | CEBPB_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.11758171 |
| 112 | ZNF263_19887448_ChIP-Seq_K562_Human | 1.11520207 |
| 113 | LMO2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.11146902 |
| 114 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 1.10892569 |
| 115 | PPARG_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.09892319 |
| 116 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 1.09831375 |
| 117 | TCF4_23295773_ChIP-Seq_U87_Human | 1.08366624 |
| 118 | TEAD4_22529382_ChIP-Seq_TROPHECTODERM_Mouse | 1.07855741 |
| 119 | GATA4_25053715_ChIP-Seq_YYC3_Human | 1.05311799 |
| 120 | AR_19668381_ChIP-Seq_PC3_Human | 1.04234923 |
| 121 | BMI1_23680149_ChIP-Seq_NPCS_Mouse | 1.04100562 |
| 122 | STAT3_24763339_ChIP-Seq_IMN-ESCs_Mouse | 1.03631285 |
| 123 | RCOR3_21632747_ChIP-Seq_MESCs_Mouse | 1.02934013 |
| 124 | NOTCH1_17114293_ChIP-ChIP_T-ALL_Human | 1.01725440 |
| 125 | UBF1/2_26484160_Chip-Seq_FIBROBLAST_Human | 1.01647204 |
| 126 | TAL1_26923725_Chip-Seq_HPCs_Mouse | 1.00915633 |
| 127 | RING1B_27294783_Chip-Seq_NPCs_Mouse | 1.00652949 |
| 128 | TP53_18474530_ChIP-ChIP_U2OS_Human | 1.00647969 |
| 129 | PDX1_19855005_ChIP-ChIP_MIN6_Mouse | 1.00069229 |
| 130 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 0.99849842 |
| 131 | STAT3_1855785_ChIP-Seq_MESCs_Mouse | 0.99035870 |
| 132 | EBF1_22473956_ChIP-Seq_BONE_MARROW_Mouse | 0.98790967 |
| 133 | * HOXB4_20404135_ChIP-ChIP_EML_Mouse | 0.98704845 |
| 134 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 0.98540582 |
| 135 | POU5F1_26923725_Chip-Seq_MESODERM_Mouse | 0.98452043 |
| 136 | TEAD4_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 0.98452043 |
| 137 | BCL11B_21912641_ChIP-Seq_STHDH_STRIUM_Mouse | 0.98401106 |
| 138 | KDM2B_26808549_Chip-Seq_REH_Human | 0.97693317 |
| 139 | P53_22387025_ChIP-Seq_ESCs_Mouse | 0.97688462 |
| 140 | JARID1A_20064375_ChIP-Seq_MESCs_Mouse | 0.97402464 |
| 141 | * SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 0.97309597 |
| 142 | SMAD4_21741376_ChIP-Seq_HESCs_Human | 0.97298251 |
| 143 | DCP1A_22483619_ChIP-Seq_HELA_Human | 0.97155609 |
| 144 | RUNX2_22187159_ChIP-Seq_PCA_Human | 0.97001678 |
| 145 | FUS_26573619_Chip-Seq_HEK293_Human | 0.96201650 |
| 146 | * MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 0.95649388 |
| 147 | * HNF4A_19822575_ChIP-Seq_HepG2_Human | 0.95550775 |
| 148 | GATA1_26923725_Chip-Seq_HPCs_Mouse | 0.94851228 |
| 149 | CMYC_18555785_Chip-Seq_ESCs_Mouse | 0.94800708 |
| 150 | EST1_17652178_ChIP-ChIP_JURKAT_Human | 0.94265489 |
| 151 | CBP_20019798_ChIP-Seq_JUKART_Human | 0.93800729 |
| 152 | CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 0.93546966 |
| 153 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 0.93335535 |
| 154 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 0.92814390 |
| 155 | E2F1_18555785_ChIP-Seq_MESCs_Mouse | 0.92791792 |
| 156 | SOX2_27498859_Chip-Seq_STOMACH_Mouse | 0.91460732 |
| 157 | FOXA1_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.88044113 |
| 158 | CUX1_19635798_ChIP-ChIP_MULTIPLE_HUMAN_CANCER_TYPES_Human | 0.85210915 |
| 159 | SALL4_18804426_ChIP-ChIP_XEN_Mouse | 0.84799330 |
| 160 | KAP1_22055183_ChIP-Seq_ESCs_Mouse | 0.84612976 |
| 161 | SREBP1_19666523_ChIP-Seq_LIVER_Mouse | 0.83666806 |
| 162 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 0.83039786 |
| 163 | CEBPA_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.82205581 |
| 164 | CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 0.82005502 |
| 165 | NELFA_20434984_ChIP-Seq_ESCs_Mouse | 0.81283741 |
| 166 | RXRA_24833708_ChIP-Seq_LIVER_Mouse | 0.80981832 |
| 167 | HTT_18923047_ChIP-ChIP_STHdh_Human | 0.80844350 |
| 168 | HSF1_23293686_ChIP-Seq_STHDH_STRIATAL_Mouse | 0.80631508 |
| 169 | * ERG_20887958_ChIP-Seq_HPC-7_Mouse | 0.78680958 |
| 170 | FOXA2_19822575_ChIP-Seq_HepG2_Human | 0.78225250 |
| 171 | GATA2_22383799_ChIP-Seq_G1ME_Mouse | 0.77204956 |
| 172 | CEBPB_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.76612558 |
| 173 | FOXP3_21729870_ChIP-Seq_TREG_Human | 0.76172145 |
| 174 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 0.75757635 |
| 175 | FOXA1_21915096_ChIP-Seq_LNCaP-1F5_Human | 0.75595749 |
| 176 | CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 0.75270501 |
| 177 | MYC_18358816_ChIP-ChIP_MESCs_Mouse | 0.75214855 |
| 178 | GATA3_24758297_ChIP-Seq_MCF-7_Human | 0.75154505 |
| 179 | MYB_26560356_Chip-Seq_TH1_Human | 0.75094530 |
| 180 | ETS2_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 0.74126058 |
| 181 | MYB_26560356_Chip-Seq_TH2_Human | 0.73167233 |
| 182 | ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 0.72575451 |
| 183 | PPARG_20887899_ChIP-Seq_3T3-L1_Mouse | 0.72570090 |
| 184 | ERG_20517297_ChIP-Seq_VCAP_Human | 0.72544903 |
| 185 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 0.71661539 |
| 186 | * ETS1_20019798_ChIP-Seq_JURKAT_Human | 0.70961330 |
| 187 | * SOX2_20726797_ChIP-Seq_SW620_Human | 0.70764420 |
| 188 | MYC_18555785_ChIP-Seq_MESCs_Mouse | 0.70667645 |
| 189 | * VDR_23849224_ChIP-Seq_CD4+_Human | 0.70559799 |
| 190 | * PADI4_21655091_ChIP-ChIP_MCF-7_Human | 0.70123337 |
| 191 | * FOXO3_22982991_ChIP-Seq_MACROPHAGES_Mouse | 0.69973784 |
| 192 | ESR1_15608294_ChIP-ChIP_MCF-7_Human | 0.69135771 |
| 193 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 0.68584912 |
| 194 | GABP_19822575_ChIP-Seq_HepG2_Human | 0.67722904 |
| 195 | GATA3_26560356_Chip-Seq_TH2_Human | 0.67518418 |
| 196 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 0.67126743 |
| 197 | SPI1_23547873_ChIP-Seq_NB4_Human | 0.66668282 |
| 198 | TCF21_23034159_ChIP-ChIP_E13_GONADS_Rat | 0.64935806 |
| 199 | AR_20517297_ChIP-Seq_VCAP_Human | 0.64839164 |
| 200 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 0.64290032 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0002139_abnormal_hepatobiliary_system | 6.47661777 |
| 2 | MP0005360_urolithiasis | 5.40070431 |
| 3 | MP0004859_abnormal_synaptic_plasticity | 4.73414912 |
| 4 | MP0005085_abnormal_gallbladder_physiolo | 4.70652543 |
| 5 | MP0005365_abnormal_bile_salt | 4.48170980 |
| 6 | MP0003806_abnormal_nucleotide_metabolis | 4.27367352 |
| 7 | MP0008875_abnormal_xenobiotic_pharmacok | 4.01998560 |
| 8 | MP0004270_analgesia | 3.58121478 |
| 9 | MP0003880_abnormal_central_pattern | 3.54625930 |
| 10 | MP0005423_abnormal_somatic_nervous | 3.03517018 |
| 11 | MP0010329_abnormal_lipoprotein_level | 2.94680712 |
| 12 | MP0003011_delayed_dark_adaptation | 2.81092732 |
| 13 | MP0003635_abnormal_synaptic_transmissio | 2.80037395 |
| 14 | MP0003252_abnormal_bile_duct | 2.76958231 |
| 15 | MP0003186_abnormal_redox_activity | 2.74275870 |
| 16 | MP0004019_abnormal_vitamin_homeostasis | 2.64986748 |
| 17 | MP0009840_abnormal_foam_cell | 2.63541853 |
| 18 | MP0005332_abnormal_amino_acid | 2.55219595 |
| 19 | MP0002822_catalepsy | 2.46290682 |
| 20 | MP0002064_seizures | 2.45926050 |
| 21 | MP0005083_abnormal_biliary_tract | 2.41646248 |
| 22 | MP0009046_muscle_twitch | 2.35214068 |
| 23 | MP0002063_abnormal_learning/memory/cond | 2.34691404 |
| 24 | MP0002272_abnormal_nervous_system | 2.31185741 |
| 25 | MP0002734_abnormal_mechanical_nocicepti | 2.29996148 |
| 26 | MP0003195_calcinosis | 2.28899382 |
| 27 | MP0001486_abnormal_startle_reflex | 2.26667378 |
| 28 | MP0001764_abnormal_homeostasis | 2.20879984 |
| 29 | MP0003191_abnormal_cellular_cholesterol | 2.19777447 |
| 30 | MP0009745_abnormal_behavioral_response | 2.16814179 |
| 31 | MP0009780_abnormal_chondrocyte_physiolo | 2.16402216 |
| 32 | MP0002735_abnormal_chemical_nociception | 2.06274507 |
| 33 | MP0000778_abnormal_nervous_system | 2.02577778 |
| 34 | MP0000609_abnormal_liver_physiology | 1.97723523 |
| 35 | MP0001984_abnormal_olfaction | 1.95551607 |
| 36 | MP0002572_abnormal_emotion/affect_behav | 1.93862544 |
| 37 | MP0001666_abnormal_nutrient_absorption | 1.90238852 |
| 38 | MP0005319_abnormal_enzyme/_coenzyme | 1.89790120 |
| 39 | MP0000751_myopathy | 1.89656694 |
| 40 | MP0001968_abnormal_touch/_nociception | 1.86480679 |
| 41 | MP0003656_abnormal_erythrocyte_physiolo | 1.86252631 |
| 42 | MP0002138_abnormal_hepatobiliary_system | 1.81002874 |
| 43 | MP0003329_amyloid_beta_deposits | 1.77794067 |
| 44 | MP0002653_abnormal_ependyma_morphology | 1.77670717 |
| 45 | MP0010386_abnormal_urinary_bladder | 1.72621973 |
| 46 | MP0009697_abnormal_copulation | 1.71388002 |
| 47 | MP0005584_abnormal_enzyme/coenzyme_acti | 1.71334242 |
| 48 | MP0008004_abnormal_stomach_pH | 1.66677442 |
| 49 | MP0002909_abnormal_adrenal_gland | 1.66632100 |
| 50 | MP0002118_abnormal_lipid_homeostasis | 1.65132169 |
| 51 | MP0001501_abnormal_sleep_pattern | 1.64046824 |
| 52 | MP0009643_abnormal_urine_homeostasis | 1.60327010 |
| 53 | MP0002736_abnormal_nociception_after | 1.52881044 |
| 54 | MP0002557_abnormal_social/conspecific_i | 1.52457278 |
| 55 | MP0004215_abnormal_myocardial_fiber | 1.48922552 |
| 56 | MP0000569_abnormal_digit_pigmentation | 1.48097887 |
| 57 | MP0004885_abnormal_endolymph | 1.47380140 |
| 58 | MP0002067_abnormal_sensory_capabilities | 1.45646437 |
| 59 | MP0001835_abnormal_antigen_presentation | 1.43393791 |
| 60 | MP0001177_atelectasis | 1.43127288 |
| 61 | MP0000955_abnormal_spinal_cord | 1.41016452 |
| 62 | MP0001970_abnormal_pain_threshold | 1.40211902 |
| 63 | MP0004811_abnormal_neuron_physiology | 1.39036151 |
| 64 | MP0003879_abnormal_hair_cell | 1.38763573 |
| 65 | MP0003724_increased_susceptibility_to | 1.34454277 |
| 66 | MP0009764_decreased_sensitivity_to | 1.34411507 |
| 67 | MP0002733_abnormal_thermal_nociception | 1.34217333 |
| 68 | MP0003633_abnormal_nervous_system | 1.33910195 |
| 69 | MP0005386_behavior/neurological_phenoty | 1.33796250 |
| 70 | MP0004924_abnormal_behavior | 1.33796250 |
| 71 | MP0001502_abnormal_circadian_rhythm | 1.32453764 |
| 72 | MP0008469_abnormal_protein_level | 1.29807197 |
| 73 | MP0002837_dystrophic_cardiac_calcinosis | 1.29458405 |
| 74 | MP0002882_abnormal_neuron_morphology | 1.29305493 |
| 75 | MP0003690_abnormal_glial_cell | 1.28525017 |
| 76 | MP0002090_abnormal_vision | 1.27475521 |
| 77 | MP0008569_lethality_at_weaning | 1.27126346 |
| 78 | MP0005646_abnormal_pituitary_gland | 1.24180944 |
| 79 | MP0005636_abnormal_mineral_homeostasis | 1.23551743 |
| 80 | MP0001299_abnormal_eye_distance/ | 1.23404004 |
| 81 | MP0006036_abnormal_mitochondrial_physio | 1.22566826 |
| 82 | MP0003122_maternal_imprinting | 1.21715598 |
| 83 | MP0009785_altered_susceptibility_to | 1.21390149 |
| 84 | MP0000598_abnormal_liver_morphology | 1.20938237 |
| 85 | MP0005248_abnormal_Harderian_gland | 1.20666770 |
| 86 | MP0006276_abnormal_autonomic_nervous | 1.18729225 |
| 87 | MP0005464_abnormal_platelet_physiology | 1.16815969 |
| 88 | MP0003436_decreased_susceptibility_to | 1.14976064 |
| 89 | MP0002066_abnormal_motor_capabilities/c | 1.14252923 |
| 90 | MP0005551_abnormal_eye_electrophysiolog | 1.13479891 |
| 91 | MP0003787_abnormal_imprinting | 1.12701994 |
| 92 | MP0001440_abnormal_grooming_behavior | 1.12124519 |
| 93 | MP0002184_abnormal_innervation | 1.11327908 |
| 94 | MP0000013_abnormal_adipose_tissue | 1.09834538 |
| 95 | MP0004742_abnormal_vestibular_system | 1.09516854 |
| 96 | MP0009763_increased_sensitivity_to | 1.08757670 |
| 97 | MP0001756_abnormal_urination | 1.08516340 |
| 98 | MP0000920_abnormal_myelination | 1.06087028 |
| 99 | MP0003631_nervous_system_phenotype | 1.05627540 |
| 100 | MP0003137_abnormal_impulse_conducting | 1.05442797 |
| 101 | MP0005058_abnormal_lysosome_morphology | 1.05241472 |
| 102 | MP0005367_renal/urinary_system_phenotyp | 1.04486816 |
| 103 | MP0000516_abnormal_urinary_system | 1.04486816 |
| 104 | MP0005408_hypopigmentation | 1.04052144 |
| 105 | MP0003634_abnormal_glial_cell | 1.00337863 |
| 106 | MP0004085_abnormal_heartbeat | 1.00265862 |
| 107 | MP0005666_abnormal_adipose_tissue | 0.99333319 |
| 108 | MP0001905_abnormal_dopamine_level | 0.99307009 |
| 109 | MP0005670_abnormal_white_adipose | 0.99210669 |
| 110 | MP0002638_abnormal_pupillary_reflex | 0.97107746 |
| 111 | MP0000534_abnormal_ureter_morphology | 0.96080182 |
| 112 | MP0005275_abnormal_skin_tensile | 0.94975713 |
| 113 | MP0005647_abnormal_sex_gland | 0.94569836 |
| 114 | MP0002229_neurodegeneration | 0.94048333 |
| 115 | MP0002152_abnormal_brain_morphology | 0.92892020 |
| 116 | MP0001853_heart_inflammation | 0.92160350 |
| 117 | MP0002166_altered_tumor_susceptibility | 0.91758960 |
| 118 | MP0002136_abnormal_kidney_physiology | 0.90504115 |
| 119 | MP0001845_abnormal_inflammatory_respons | 0.90236026 |
| 120 | MP0005253_abnormal_eye_physiology | 0.90089951 |
| 121 | MP0005025_abnormal_response_to | 0.89853545 |
| 122 | MP0001346_abnormal_lacrimal_gland | 0.89357186 |
| 123 | MP0003385_abnormal_body_wall | 0.88379145 |
| 124 | MP0005451_abnormal_body_composition | 0.87760168 |
| 125 | MP0002876_abnormal_thyroid_physiology | 0.87534310 |
| 126 | MP0009765_abnormal_xenobiotic_induced | 0.87405663 |
| 127 | MP0004782_abnormal_surfactant_physiolog | 0.87376919 |
| 128 | MP0005376_homeostasis/metabolism_phenot | 0.87333004 |
| 129 | MP0001986_abnormal_taste_sensitivity | 0.87305685 |
| 130 | MP0009642_abnormal_blood_homeostasis | 0.87266413 |
| 131 | MP0004142_abnormal_muscle_tone | 0.86743677 |
| 132 | MP0003868_abnormal_feces_composition | 0.86607819 |
| 133 | MP0010234_abnormal_vibrissa_follicle | 0.86172026 |
| 134 | MP0005503_abnormal_tendon_morphology | 0.85787252 |
| 135 | MP0005167_abnormal_blood-brain_barrier | 0.85065152 |
| 136 | MP0003938_abnormal_ear_development | 0.84850949 |
| 137 | MP0002102_abnormal_ear_morphology | 0.83664623 |
| 138 | MP0002971_abnormal_brown_adipose | 0.82695929 |
| 139 | MP0000462_abnormal_digestive_system | 0.82082228 |
| 140 | MP0005671_abnormal_response_to | 0.81823835 |
| 141 | MP0000604_amyloidosis | 0.81670243 |
| 142 | MP0002234_abnormal_pharynx_morphology | 0.81279625 |
| 143 | MP0001963_abnormal_hearing_physiology | 0.80914926 |
| 144 | MP0000566_synostosis | 0.80847440 |
| 145 | MP0005645_abnormal_hypothalamus_physiol | 0.80785007 |
| 146 | MP0006082_CNS_inflammation | 0.79939154 |
| 147 | MP0000026_abnormal_inner_ear | 0.78823640 |
| 148 | MP0002419_abnormal_innate_immunity | 0.76229114 |
| 149 | MP0000685_abnormal_immune_system | 0.75075982 |
| 150 | MP0002132_abnormal_respiratory_system | 0.74532058 |
| 151 | MP0001485_abnormal_pinna_reflex | 0.74425633 |
| 152 | MP0005187_abnormal_penis_morphology | 0.74175424 |
| 153 | MP0003632_abnormal_nervous_system | 0.72194851 |
| 154 | MP0005535_abnormal_body_temperature | 0.71575353 |
| 155 | MP0002295_abnormal_pulmonary_circulatio | 0.70415866 |
| 156 | MP0002752_abnormal_somatic_nervous | 0.70106731 |
| 157 | MP0001188_hyperpigmentation | 0.69707233 |
| 158 | MP0005397_hematopoietic_system_phenotyp | 0.69387335 |
| 159 | MP0001545_abnormal_hematopoietic_system | 0.69387335 |
| 160 | MP0005623_abnormal_meninges_morphology | 0.69352869 |
| 161 | MP0010155_abnormal_intestine_physiology | 0.69009986 |
| 162 | MP0002069_abnormal_eating/drinking_beha | 0.68407393 |
| 163 | MP0001800_abnormal_humoral_immune | 0.67883961 |
| 164 | MP0001873_stomach_inflammation | 0.67654599 |
| 165 | MP0002078_abnormal_glucose_homeostasis | 0.67114292 |
| 166 | MP0004947_skin_inflammation | 0.66386695 |
| 167 | MP0005620_abnormal_muscle_contractility | 0.66278278 |
| 168 | MP0001790_abnormal_immune_system | 0.66196202 |
| 169 | MP0005387_immune_system_phenotype | 0.66196202 |
| 170 | MP0004084_abnormal_cardiac_muscle | 0.65924289 |
| 171 | MP0004043_abnormal_pH_regulation | 0.65718580 |
| 172 | MP0003300_gastrointestinal_ulcer | 0.65392772 |
| 173 | MP0001958_emphysema | 0.65150689 |
| 174 | MP0002148_abnormal_hypersensitivity_rea | 0.64986405 |
| 175 | MP0003705_abnormal_hypodermis_morpholog | 0.64490415 |
| 176 | MP0005395_other_phenotype | 0.64418226 |
| 177 | MP0005266_abnormal_metabolism | 0.64401748 |
| 178 | MP0005220_abnormal_exocrine_pancreas | 0.63246830 |
| 179 | MP0008873_increased_physiological_sensi | 0.63237465 |
| 180 | MP0001542_abnormal_bone_strength | 0.62887552 |
| 181 | MP0001661_extended_life_span | 0.62247702 |
| 182 | MP0004130_abnormal_muscle_cell | 0.61787745 |
| 183 | MP0005334_abnormal_fat_pad | 0.61692872 |
| 184 | MP0001533_abnormal_skeleton_physiology | 0.61233906 |
| 185 | MP0001765_abnormal_ion_homeostasis | 0.60807048 |
| 186 | MP0005000_abnormal_immune_tolerance | 0.60724809 |
| 187 | MP0003718_maternal_effect | 0.59759223 |
| 188 | MP0001881_abnormal_mammary_gland | 0.59237137 |
| 189 | MP0000249_abnormal_blood_vessel | 0.57844377 |
| 190 | MP0005075_abnormal_melanosome_morpholog | 0.57107739 |
| 191 | MP0002723_abnormal_immune_serum | 0.57102003 |
| 192 | MP0002254_reproductive_system_inflammat | 0.55012606 |
| 193 | MP0002928_abnormal_bile_duct | 0.54179368 |
| 194 | MP0002006_tumorigenesis | 0.53730365 |
| 195 | MP0002168_other_aberrant_phenotype | 0.53450807 |
| 196 | MP0002970_abnormal_white_adipose | 0.53450316 |
| 197 | MP0005166_decreased_susceptibility_to | 0.52201918 |
| 198 | MP0009115_abnormal_fat_cell | 0.52176478 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 5.66675061 |
| 2 | Abnormality of monocarboxylic acid metabolism (HP:0010996) | 5.37434397 |
| 3 | Deep venous thrombosis (HP:0002625) | 5.37293070 |
| 4 | Hypobetalipoproteinemia (HP:0003563) | 5.15277179 |
| 5 | Intrahepatic cholestasis (HP:0001406) | 5.11196834 |
| 6 | Myokymia (HP:0002411) | 4.80211263 |
| 7 | Xanthomatosis (HP:0000991) | 4.70005637 |
| 8 | Prolonged partial thromboplastin time (HP:0003645) | 4.68694363 |
| 9 | Focal motor seizures (HP:0011153) | 4.58185494 |
| 10 | Action tremor (HP:0002345) | 4.27833703 |
| 11 | Hypolipoproteinemia (HP:0010981) | 4.23249555 |
| 12 | Complement deficiency (HP:0004431) | 4.16992612 |
| 13 | Hyperammonemia (HP:0001987) | 3.93425928 |
| 14 | Abnormality of fatty-acid metabolism (HP:0004359) | 3.93051616 |
| 15 | Hyperglycinuria (HP:0003108) | 3.92095062 |
| 16 | Hyperlipoproteinemia (HP:0010980) | 3.90663623 |
| 17 | Hypoalphalipoproteinemia (HP:0003233) | 3.87933437 |
| 18 | Hyperglycinemia (HP:0002154) | 3.84040609 |
| 19 | Vascular calcification (HP:0004934) | 3.83133335 |
| 20 | Focal seizures (HP:0007359) | 3.77821287 |
| 21 | Abnormality of sulfur amino acid metabolism (HP:0004339) | 3.77493865 |
| 22 | Abnormality of the level of lipoprotein cholesterol (HP:0010979) | 3.77306641 |
| 23 | Abnormality of methionine metabolism (HP:0010901) | 3.74359248 |
| 24 | Abnormality of the common coagulation pathway (HP:0010990) | 3.65762901 |
| 25 | Abnormality of aspartate family amino acid metabolism (HP:0010899) | 3.60560961 |
| 26 | Abnormality of serine family amino acid metabolism (HP:0010894) | 3.57487871 |
| 27 | Abnormality of glycine metabolism (HP:0010895) | 3.57487871 |
| 28 | Ketosis (HP:0001946) | 3.49534358 |
| 29 | Hypoglycemic coma (HP:0001325) | 3.49077571 |
| 30 | Joint hemorrhage (HP:0005261) | 3.44285442 |
| 31 | Generalized aminoaciduria (HP:0002909) | 3.44252217 |
| 32 | Cardiovascular calcification (HP:0011915) | 3.39520257 |
| 33 | Fat malabsorption (HP:0002630) | 3.34393316 |
| 34 | Abnormality of glutamine family amino acid metabolism (HP:0010902) | 3.34057610 |
| 35 | Neurofibrillary tangles (HP:0002185) | 3.30651316 |
| 36 | Abnormality of long-chain fatty-acid metabolism (HP:0010964) | 3.27860294 |
| 37 | Epidermoid cyst (HP:0200040) | 3.24541624 |
| 38 | Abnormality of pyrimidine metabolism (HP:0004353) | 3.24017362 |
| 39 | Febrile seizures (HP:0002373) | 3.18851468 |
| 40 | Abnormality of complement system (HP:0005339) | 3.13567932 |
| 41 | Abnormality of the intrinsic pathway (HP:0010989) | 3.13551588 |
| 42 | Polyphagia (HP:0002591) | 3.11124385 |
| 43 | Abnormal eating behavior (HP:0100738) | 3.09239113 |
| 44 | Abnormality of nucleobase metabolism (HP:0010932) | 3.07592543 |
| 45 | Gait imbalance (HP:0002141) | 3.06712069 |
| 46 | Urinary urgency (HP:0000012) | 3.00505703 |
| 47 | Abnormality of purine metabolism (HP:0004352) | 2.99380133 |
| 48 | Epileptic encephalopathy (HP:0200134) | 2.99218184 |
| 49 | Hyperbilirubinemia (HP:0002904) | 2.97497033 |
| 50 | Spastic gait (HP:0002064) | 2.89367027 |
| 51 | Atrophy/Degeneration involving the corticospinal tracts (HP:0007372) | 2.87272318 |
| 52 | Degeneration of the lateral corticospinal tracts (HP:0002314) | 2.87272318 |
| 53 | Ankle clonus (HP:0011448) | 2.81866725 |
| 54 | Steatorrhea (HP:0002570) | 2.76515052 |
| 55 | Systemic lupus erythematosus (HP:0002725) | 2.76161803 |
| 56 | Absent speech (HP:0001344) | 2.74954051 |
| 57 | Abnormality of the corticospinal tract (HP:0002492) | 2.73265726 |
| 58 | Abnormality of serum amino acid levels (HP:0003112) | 2.73135653 |
| 59 | Impaired vibration sensation in the lower limbs (HP:0002166) | 2.72900937 |
| 60 | Intention tremor (HP:0002080) | 2.71229952 |
| 61 | Lethargy (HP:0001254) | 2.69118570 |
| 62 | Ketoacidosis (HP:0001993) | 2.67945952 |
| 63 | Acanthocytosis (HP:0001927) | 2.67210112 |
| 64 | Lower limb muscle weakness (HP:0007340) | 2.67158139 |
| 65 | Gout (HP:0001997) | 2.65426883 |
| 66 | Congenital primary aphakia (HP:0007707) | 2.63050793 |
| 67 | Hyperventilation (HP:0002883) | 2.63001625 |
| 68 | Supranuclear gaze palsy (HP:0000605) | 2.62556414 |
| 69 | Dicarboxylic aciduria (HP:0003215) | 2.59144312 |
| 70 | Abnormality of dicarboxylic acid metabolism (HP:0010995) | 2.59144312 |
| 71 | Hypercholesterolemia (HP:0003124) | 2.58510053 |
| 72 | Nephrogenic diabetes insipidus (HP:0009806) | 2.58372033 |
| 73 | Myocardial infarction (HP:0001658) | 2.57817892 |
| 74 | Drooling (HP:0002307) | 2.50903883 |
| 75 | Bundle branch block (HP:0011710) | 2.49748253 |
| 76 | Conjugated hyperbilirubinemia (HP:0002908) | 2.48955309 |
| 77 | Generalized tonic-clonic seizures (HP:0002069) | 2.48002750 |
| 78 | Epileptiform EEG discharges (HP:0011182) | 2.47959521 |
| 79 | Increased circulating renin level (HP:0000848) | 2.47763760 |
| 80 | Atonic seizures (HP:0010819) | 2.47127623 |
| 81 | Limb dystonia (HP:0002451) | 2.44504541 |
| 82 | Cerebral inclusion bodies (HP:0100314) | 2.42070783 |
| 83 | Renal cortical cysts (HP:0000803) | 2.40560172 |
| 84 | Recurrent gram-negative bacterial infections (HP:0005420) | 2.39302573 |
| 85 | Metabolic acidosis (HP:0001942) | 2.38939244 |
| 86 | Delayed CNS myelination (HP:0002188) | 2.38427503 |
| 87 | Urinary bladder sphincter dysfunction (HP:0002839) | 2.37758666 |
| 88 | EEG with generalized epileptiform discharges (HP:0011198) | 2.37469174 |
| 89 | Nausea (HP:0002018) | 2.36058299 |
| 90 | Hepatocellular carcinoma (HP:0001402) | 2.34124954 |
| 91 | Pancreatitis (HP:0001733) | 2.33691876 |
| 92 | Insidious onset (HP:0003587) | 2.33455998 |
| 93 | Termporal pattern (HP:0011008) | 2.33455998 |
| 94 | Spontaneous abortion (HP:0005268) | 2.29623726 |
| 95 | Glomerulonephritis (HP:0000099) | 2.28819312 |
| 96 | Hemiparesis (HP:0001269) | 2.27072386 |
| 97 | Proximal tubulopathy (HP:0000114) | 2.26225906 |
| 98 | Increased purine levels (HP:0004368) | 2.25385339 |
| 99 | Hyperuricemia (HP:0002149) | 2.25385339 |
| 100 | Amblyopia (HP:0000646) | 2.24860672 |
| 101 | Medial flaring of the eyebrow (HP:0010747) | 2.24723598 |
| 102 | Cerebral edema (HP:0002181) | 2.23346611 |
| 103 | Hypertriglyceridemia (HP:0002155) | 2.22738774 |
| 104 | Menorrhagia (HP:0000132) | 2.22120126 |
| 105 | Excessive salivation (HP:0003781) | 2.21348517 |
| 106 | Dialeptic seizures (HP:0011146) | 2.20343868 |
| 107 | Hypsarrhythmia (HP:0002521) | 2.20329289 |
| 108 | Cholelithiasis (HP:0001081) | 2.19963926 |
| 109 | Neoplasm of the heart (HP:0100544) | 2.19939981 |
| 110 | Progressive cerebellar ataxia (HP:0002073) | 2.18494446 |
| 111 | Abnormal gallbladder morphology (HP:0012437) | 2.17139865 |
| 112 | Broad-based gait (HP:0002136) | 2.14854854 |
| 113 | Truncal ataxia (HP:0002078) | 2.13802434 |
| 114 | Nephritis (HP:0000123) | 2.08521454 |
| 115 | Genital tract atresia (HP:0001827) | 2.08506331 |
| 116 | Absence seizures (HP:0002121) | 2.08116958 |
| 117 | Vaginal atresia (HP:0000148) | 2.07204378 |
| 118 | Abnormality of urine glucose concentration (HP:0011016) | 2.06878787 |
| 119 | Glycosuria (HP:0003076) | 2.06878787 |
| 120 | Malnutrition (HP:0004395) | 2.05239678 |
| 121 | Syncope (HP:0001279) | 2.05238686 |
| 122 | Irritability (HP:0000737) | 2.05123931 |
| 123 | Mutism (HP:0002300) | 2.05062381 |
| 124 | Gingival bleeding (HP:0000225) | 2.04401983 |
| 125 | Ulnar claw (HP:0001178) | 2.03589417 |
| 126 | Dysdiadochokinesis (HP:0002075) | 2.03182161 |
| 127 | Abnormality of vitamin metabolism (HP:0100508) | 2.00739931 |
| 128 | Esophageal varix (HP:0002040) | 1.98570405 |
| 129 | Abnormality of renal resorption (HP:0011038) | 1.97390901 |
| 130 | Dysmetria (HP:0001310) | 1.96609428 |
| 131 | Vomiting (HP:0002013) | 1.95997914 |
| 132 | Paraplegia (HP:0010550) | 1.94578956 |
| 133 | Peripheral hypomyelination (HP:0007182) | 1.93496277 |
| 134 | Elevated hepatic transaminases (HP:0002910) | 1.93299340 |
| 135 | Cholecystitis (HP:0001082) | 1.92478943 |
| 136 | Abnormal gallbladder physiology (HP:0012438) | 1.92478943 |
| 137 | Sleep apnea (HP:0010535) | 1.92271539 |
| 138 | Decreased number of large peripheral myelinated nerve fibers (HP:0003387) | 1.91955962 |
| 139 | Morphological abnormality of the pyramidal tract (HP:0002062) | 1.91644531 |
| 140 | Mitral stenosis (HP:0001718) | 1.89908446 |
| 141 | Specific learning disability (HP:0001328) | 1.87639248 |
| 142 | Increased CSF protein (HP:0002922) | 1.87290465 |
| 143 | Thrombophlebitis (HP:0004418) | 1.86930160 |
| 144 | Papillary thyroid carcinoma (HP:0002895) | 1.86884707 |
| 145 | Torticollis (HP:0000473) | 1.86394234 |
| 146 | Brushfield spots (HP:0001088) | 1.83432895 |
| 147 | Spastic paraplegia (HP:0001258) | 1.82548860 |
| 148 | Poikilocytosis (HP:0004447) | 1.81800750 |
| 149 | Megalencephaly (HP:0001355) | 1.79694160 |
| 150 | Sensorimotor neuropathy (HP:0007141) | 1.79581826 |
| 151 | Abnormality of transition element cation homeostasis (HP:0011030) | 1.79434588 |
| 152 | Neonatal onset (HP:0003623) | 1.78617926 |
| 153 | Spastic diplegia (HP:0001264) | 1.78491067 |
| 154 | Abnormality of iron homeostasis (HP:0011031) | 1.78384445 |
| 155 | Hypoplasia of the corpus callosum (HP:0002079) | 1.78383736 |
| 156 | Vacuolated lymphocytes (HP:0001922) | 1.78196569 |
| 157 | Hemorrhage of the eye (HP:0011885) | 1.76823217 |
| 158 | Hammertoe (HP:0001765) | 1.76715749 |
| 159 | Amyloidosis (HP:0011034) | 1.75084461 |
| 160 | Gait ataxia (HP:0002066) | 1.74926397 |
| 161 | Spastic tetraparesis (HP:0001285) | 1.73821054 |
| 162 | Impaired vibratory sensation (HP:0002495) | 1.71953045 |
| 163 | Late onset (HP:0003584) | 1.71438545 |
| 164 | Alacrima (HP:0000522) | 1.70380450 |
| 165 | Abnormal enzyme/coenzyme activity (HP:0012379) | 1.70219112 |
| 166 | Poor coordination (HP:0002370) | 1.70187982 |
| 167 | Anxiety (HP:0000739) | 1.69325210 |
| 168 | Acute hepatic failure (HP:0006554) | 1.69046815 |
| 169 | Methylmalonic aciduria (HP:0012120) | 1.67702666 |
| 170 | Abnormality of the calf musculature (HP:0001430) | 1.67659890 |
| 171 | Hepatic necrosis (HP:0002605) | 1.67563497 |
| 172 | Upper motor neuron abnormality (HP:0002127) | 1.67001951 |
| 173 | Spastic tetraplegia (HP:0002510) | 1.66975959 |
| 174 | Hydroxyprolinuria (HP:0003080) | 1.66758311 |
| 175 | Split foot (HP:0001839) | 1.65101384 |
| 176 | Hyperaldosteronism (HP:0000859) | 1.64992636 |
| 177 | Frequent falls (HP:0002359) | 1.64665001 |
| 178 | Heterochromia iridis (HP:0001100) | 1.64615123 |
| 179 | Depression (HP:0000716) | 1.63556813 |
| 180 | Apathy (HP:0000741) | 1.63205782 |
| 181 | Shoulder girdle muscle weakness (HP:0003547) | 1.62354418 |
| 182 | Exotropia (HP:0000577) | 1.61054296 |
| 183 | Rapidly progressive (HP:0003678) | 1.58841035 |
| 184 | Aplasia/Hypoplasia of the lens (HP:0008063) | 1.58269148 |
| 185 | Amyotrophic lateral sclerosis (HP:0007354) | 1.58046633 |
| 186 | Decreased number of peripheral myelinated nerve fibers (HP:0003380) | 1.56936476 |
| 187 | Poor eye contact (HP:0000817) | 1.56533742 |
| 188 | Prolonged QT interval (HP:0001657) | 1.55844679 |
| 189 | Pheochromocytoma (HP:0002666) | 1.55321321 |
| 190 | True hermaphroditism (HP:0010459) | 1.54541726 |
| 191 | Sudden death (HP:0001699) | 1.52642272 |
| 192 | Left ventricular hypertrophy (HP:0001712) | 1.52195883 |
| 193 | Hyporeflexia of lower limbs (HP:0002600) | 1.51984704 |
| 194 | Decreased lacrimation (HP:0000633) | 1.51612537 |
| 195 | Scanning speech (HP:0002168) | 1.49663217 |
| 196 | Neuronal loss in central nervous system (HP:0002529) | 1.49636166 |
| 197 | Esotropia (HP:0000565) | 1.49104598 |
| 198 | Hypokalemic alkalosis (HP:0001949) | 1.49088703 |
| 199 | Intellectual disability, moderate (HP:0002342) | 1.48511847 |
| 200 | Thickened helices (HP:0000391) | 1.48058837 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | BCKDK | 4.42373474 |
| 2 | MARK1 | 3.97338050 |
| 3 | EPHA4 | 3.51671471 |
| 4 | CASK | 3.04812084 |
| 5 | NEK9 | 3.03017967 |
| 6 | ERN1 | 2.90919456 |
| 7 | FRK | 2.89176241 |
| 8 | PRKD3 | 2.82218670 |
| 9 | BCR | 2.36337623 |
| 10 | TYK2 | 2.34780187 |
| 11 | NTRK3 | 2.32014055 |
| 12 | ACVR1B | 2.28829922 |
| 13 | FGFR4 | 2.26544559 |
| 14 | UHMK1 | 2.18973500 |
| 15 | FLT3 | 2.11414434 |
| 16 | MST4 | 2.04919209 |
| 17 | MAPK13 | 1.98540141 |
| 18 | MAP3K14 | 1.97176426 |
| 19 | LATS2 | 1.96334289 |
| 20 | DAPK2 | 1.94516443 |
| 21 | PAK6 | 1.93707670 |
| 22 | NTRK2 | 1.91460184 |
| 23 | MAP3K4 | 1.86000841 |
| 24 | SIK1 | 1.82786515 |
| 25 | MAP2K7 | 1.81577954 |
| 26 | MINK1 | 1.81561848 |
| 27 | LIMK1 | 1.79370988 |
| 28 | EIF2AK1 | 1.77759018 |
| 29 | PAK3 | 1.69015059 |
| 30 | TESK1 | 1.68367776 |
| 31 | PLK2 | 1.65936050 |
| 32 | TBK1 | 1.65595814 |
| 33 | PTK6 | 1.63363903 |
| 34 | PIK3CG | 1.58763415 |
| 35 | CAMKK2 | 1.50066561 |
| 36 | TAOK3 | 1.49625213 |
| 37 | DDR2 | 1.48906428 |
| 38 | JAK3 | 1.42337292 |
| 39 | PINK1 | 1.42250444 |
| 40 | NTRK1 | 1.42187203 |
| 41 | LRRK2 | 1.38818467 |
| 42 | PKN2 | 1.38685981 |
| 43 | PDK4 | 1.35308594 |
| 44 | PDK3 | 1.35308594 |
| 45 | JAK1 | 1.31328809 |
| 46 | MAP2K3 | 1.30642973 |
| 47 | CDK5 | 1.30410026 |
| 48 | CAMKK1 | 1.27500081 |
| 49 | SGK494 | 1.27329319 |
| 50 | SGK223 | 1.27329319 |
| 51 | MAP4K2 | 1.27071330 |
| 52 | MAP3K11 | 1.26132510 |
| 53 | MAP4K1 | 1.25344833 |
| 54 | PDK2 | 1.24827424 |
| 55 | IRAK3 | 1.24441387 |
| 56 | BRSK2 | 1.23334200 |
| 57 | JAK2 | 1.22438752 |
| 58 | CAMK1G | 1.21594673 |
| 59 | WNK4 | 1.21547007 |
| 60 | ZAP70 | 1.20838071 |
| 61 | STK10 | 1.18975277 |
| 62 | WNK3 | 1.18617639 |
| 63 | ARAF | 1.17405092 |
| 64 | MST1R | 1.16640372 |
| 65 | AKT3 | 1.16632004 |
| 66 | TRIB3 | 1.16014699 |
| 67 | IKBKE | 1.15150471 |
| 68 | FER | 1.15114548 |
| 69 | NEK1 | 1.14509923 |
| 70 | CAMK2B | 1.14433659 |
| 71 | FGFR3 | 1.12374330 |
| 72 | CAMK1D | 1.11142476 |
| 73 | CSF1R | 1.08076451 |
| 74 | PIM2 | 1.07519567 |
| 75 | GRK5 | 1.07063494 |
| 76 | MAP3K5 | 1.06959284 |
| 77 | ABL2 | 1.06132139 |
| 78 | CSNK1G2 | 1.04973884 |
| 79 | CAMK1 | 1.03913740 |
| 80 | MAP3K3 | 1.00718973 |
| 81 | MAPKAPK3 | 0.99291692 |
| 82 | MAP2K4 | 0.98605906 |
| 83 | PBK | 0.98010624 |
| 84 | TESK2 | 0.97817340 |
| 85 | TRIM28 | 0.96777377 |
| 86 | BTK | 0.96381153 |
| 87 | ERBB3 | 0.95965557 |
| 88 | PRKCG | 0.94431526 |
| 89 | DMPK | 0.94130250 |
| 90 | NME2 | 0.93776567 |
| 91 | STK16 | 0.92412307 |
| 92 | PHKG1 | 0.89593768 |
| 93 | PHKG2 | 0.89593768 |
| 94 | CAMK2A | 0.88790481 |
| 95 | CDK6 | 0.88609145 |
| 96 | MAPK11 | 0.87687041 |
| 97 | CAMK2G | 0.86978199 |
| 98 | MAP3K9 | 0.86126970 |
| 99 | STK39 | 0.86096297 |
| 100 | KDR | 0.85547128 |
| 101 | TEC | 0.85361443 |
| 102 | STK38 | 0.85149355 |
| 103 | MAP3K12 | 0.84154868 |
| 104 | EIF2AK3 | 0.82944760 |
| 105 | PRKCE | 0.82310381 |
| 106 | PNCK | 0.82205257 |
| 107 | KIT | 0.81271108 |
| 108 | BUB1 | 0.80535866 |
| 109 | TGFBR1 | 0.78298806 |
| 110 | IKBKB | 0.76385433 |
| 111 | RPS6KA4 | 0.74368995 |
| 112 | MYLK | 0.73845728 |
| 113 | GRK1 | 0.72992471 |
| 114 | NEK6 | 0.72340448 |
| 115 | TXK | 0.72228913 |
| 116 | STK38L | 0.70332746 |
| 117 | DYRK1A | 0.68633734 |
| 118 | STK3 | 0.67384775 |
| 119 | ROCK2 | 0.67188896 |
| 120 | MAPKAPK5 | 0.66723392 |
| 121 | PRKCH | 0.66208343 |
| 122 | CAMK4 | 0.66105382 |
| 123 | CDK14 | 0.66040792 |
| 124 | SIK3 | 0.65783382 |
| 125 | SCYL2 | 0.65720696 |
| 126 | PRKCZ | 0.64583944 |
| 127 | CSNK1G3 | 0.64216777 |
| 128 | CDK18 | 0.64027486 |
| 129 | CSNK1A1L | 0.63230084 |
| 130 | MAP2K6 | 0.62644850 |
| 131 | PDGFRA | 0.61892954 |
| 132 | TYRO3 | 0.61600991 |
| 133 | SIK2 | 0.60741750 |
| 134 | ROCK1 | 0.60704498 |
| 135 | PKN1 | 0.60574035 |
| 136 | DYRK2 | 0.60399070 |
| 137 | CDK15 | 0.59563545 |
| 138 | MATK | 0.59256913 |
| 139 | SGK2 | 0.58946822 |
| 140 | PLK4 | 0.58368711 |
| 141 | ERBB4 | 0.58124896 |
| 142 | CHUK | 0.57251768 |
| 143 | CAMK2D | 0.57200049 |
| 144 | LATS1 | 0.55427006 |
| 145 | CDK11A | 0.54217189 |
| 146 | KSR1 | 0.54176385 |
| 147 | BRSK1 | 0.53913998 |
| 148 | MAPK10 | 0.53676131 |
| 149 | CCNB1 | 0.53513053 |
| 150 | PIM1 | 0.53225138 |
| 151 | FGFR2 | 0.51743946 |
| 152 | RPS6KB1 | 0.50691474 |
| 153 | WEE1 | 0.49121871 |
| 154 | TSSK6 | 0.48659180 |
| 155 | CSNK1G1 | 0.48176771 |
| 156 | DAPK3 | 0.47895107 |
| 157 | MELK | 0.47728551 |
| 158 | SYK | 0.47543898 |
| 159 | DAPK1 | 0.47213777 |
| 160 | RIPK1 | 0.46920695 |
| 161 | MAPK4 | 0.46902242 |
| 162 | CDK4 | 0.46861810 |
| 163 | NUAK1 | 0.46442185 |
| 164 | TRPM7 | 0.46319677 |
| 165 | CSNK1A1 | 0.45757750 |
| 166 | BRD4 | 0.44767494 |
| 167 | PRKAA1 | 0.43944762 |
| 168 | MAP3K6 | 0.43543505 |
| 169 | EPHA3 | 0.43448474 |
| 170 | EPHA2 | 0.43352444 |
| 171 | SGK3 | 0.43325357 |
| 172 | DYRK1B | 0.43303063 |
| 173 | MAP2K1 | 0.43284276 |
| 174 | NEK2 | 0.42649523 |
| 175 | MARK2 | 0.41044220 |
| 176 | BMPR1B | 0.40688340 |
| 177 | TNIK | 0.39718034 |
| 178 | RPS6KA3 | 0.39489517 |
| 179 | ITK | 0.39379935 |
| 180 | LMTK2 | 0.38075518 |
| 181 | PRKCQ | 0.37579486 |
| 182 | LYN | 0.37178461 |
| 183 | PIK3CA | 0.36802758 |
| 184 | CSK | 0.35341566 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 3.65542491 |
| 2 | Synaptic vesicle cycle_Homo sapiens_hsa04721 | 3.25521121 |
| 3 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 3.13411375 |
| 4 | Nicotine addiction_Homo sapiens_hsa05033 | 3.09499096 |
| 5 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 3.01998682 |
| 6 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 2.96115820 |
| 7 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 2.61989479 |
| 8 | GABAergic synapse_Homo sapiens_hsa04727 | 2.53037191 |
| 9 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 2.50746961 |
| 10 | Nitrogen metabolism_Homo sapiens_hsa00910 | 2.46713918 |
| 11 | Arginine biosynthesis_Homo sapiens_hsa00220 | 2.46528798 |
| 12 | Fatty acid degradation_Homo sapiens_hsa00071 | 2.43854445 |
| 13 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 2.39016217 |
| 14 | Tryptophan metabolism_Homo sapiens_hsa00380 | 2.34863746 |
| 15 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 2.33106777 |
| 16 | Propanoate metabolism_Homo sapiens_hsa00640 | 2.32142698 |
| 17 | Retrograde endocannabinoid signaling_Homo sapiens_hsa04723 | 2.28858883 |
| 18 | Circadian entrainment_Homo sapiens_hsa04713 | 2.23624908 |
| 19 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | 2.18020620 |
| 20 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 2.14042410 |
| 21 | Morphine addiction_Homo sapiens_hsa05032 | 2.10772858 |
| 22 | Peroxisome_Homo sapiens_hsa04146 | 2.09161646 |
| 23 | Insulin secretion_Homo sapiens_hsa04911 | 2.08172438 |
| 24 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 2.06165460 |
| 25 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 2.05588144 |
| 26 | Glutamatergic synapse_Homo sapiens_hsa04724 | 2.02203954 |
| 27 | Amphetamine addiction_Homo sapiens_hsa05031 | 2.01287246 |
| 28 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 1.98393962 |
| 29 | Dopaminergic synapse_Homo sapiens_hsa04728 | 1.94329924 |
| 30 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 1.87801876 |
| 31 | Cocaine addiction_Homo sapiens_hsa05030 | 1.83258569 |
| 32 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 1.82286969 |
| 33 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 1.81868353 |
| 34 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 1.81186527 |
| 35 | Fatty acid metabolism_Homo sapiens_hsa01212 | 1.76441831 |
| 36 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 1.75469262 |
| 37 | Histidine metabolism_Homo sapiens_hsa00340 | 1.73942017 |
| 38 | Selenocompound metabolism_Homo sapiens_hsa00450 | 1.72003429 |
| 39 | Butanoate metabolism_Homo sapiens_hsa00650 | 1.71947442 |
| 40 | Retinol metabolism_Homo sapiens_hsa00830 | 1.71693365 |
| 41 | PPAR signaling pathway_Homo sapiens_hsa03320 | 1.70885245 |
| 42 | Caffeine metabolism_Homo sapiens_hsa00232 | 1.70685643 |
| 43 | Long-term potentiation_Homo sapiens_hsa04720 | 1.66721694 |
| 44 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 1.61488712 |
| 45 | Adrenergic signaling in cardiomyocytes_Homo sapiens_hsa04261 | 1.61230272 |
| 46 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 1.60922194 |
| 47 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 1.58221322 |
| 48 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 1.58102239 |
| 49 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 1.58058129 |
| 50 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 1.55962495 |
| 51 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 1.52606277 |
| 52 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 1.51947777 |
| 53 | Gastric acid secretion_Homo sapiens_hsa04971 | 1.49439587 |
| 54 | Pyruvate metabolism_Homo sapiens_hsa00620 | 1.49436829 |
| 55 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 1.48993484 |
| 56 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 1.44179067 |
| 57 | Salivary secretion_Homo sapiens_hsa04970 | 1.43398625 |
| 58 | Folate biosynthesis_Homo sapiens_hsa00790 | 1.42824136 |
| 59 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 1.40210294 |
| 60 | Carbon metabolism_Homo sapiens_hsa01200 | 1.39101910 |
| 61 | Sulfur metabolism_Homo sapiens_hsa00920 | 1.38485943 |
| 62 | Cholinergic synapse_Homo sapiens_hsa04725 | 1.34819016 |
| 63 | Fatty acid elongation_Homo sapiens_hsa00062 | 1.31567555 |
| 64 | Renin secretion_Homo sapiens_hsa04924 | 1.30301655 |
| 65 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 1.30110337 |
| 66 | cAMP signaling pathway_Homo sapiens_hsa04024 | 1.26634108 |
| 67 | Tyrosine metabolism_Homo sapiens_hsa00350 | 1.25930308 |
| 68 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 1.23398542 |
| 69 | Long-term depression_Homo sapiens_hsa04730 | 1.23110062 |
| 70 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 1.22437193 |
| 71 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 1.21413997 |
| 72 | Oxytocin signaling pathway_Homo sapiens_hsa04921 | 1.20970787 |
| 73 | Taste transduction_Homo sapiens_hsa04742 | 1.18465688 |
| 74 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 1.17592214 |
| 75 | Circadian rhythm_Homo sapiens_hsa04710 | 1.12541825 |
| 76 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 1.11564967 |
| 77 | Bile secretion_Homo sapiens_hsa04976 | 1.11440042 |
| 78 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 1.08503483 |
| 79 | Gap junction_Homo sapiens_hsa04540 | 1.06005131 |
| 80 | ABC transporters_Homo sapiens_hsa02010 | 1.04871503 |
| 81 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 1.04452048 |
| 82 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 1.04032832 |
| 83 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | 1.00738318 |
| 84 | Glutathione metabolism_Homo sapiens_hsa00480 | 0.98200465 |
| 85 | Calcium signaling pathway_Homo sapiens_hsa04020 | 0.98039397 |
| 86 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 0.97471131 |
| 87 | Serotonergic synapse_Homo sapiens_hsa04726 | 0.97165973 |
| 88 | cGMP-PKG signaling pathway_Homo sapiens_hsa04022 | 0.95909845 |
| 89 | Axon guidance_Homo sapiens_hsa04360 | 0.94935146 |
| 90 | One carbon pool by folate_Homo sapiens_hsa00670 | 0.94489242 |
| 91 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 0.93787725 |
| 92 | Fat digestion and absorption_Homo sapiens_hsa04975 | 0.92707774 |
| 93 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 0.91249443 |
| 94 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.90100632 |
| 95 | Melanogenesis_Homo sapiens_hsa04916 | 0.89033474 |
| 96 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 0.88315630 |
| 97 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 0.88067967 |
| 98 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.87092557 |
| 99 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 0.85750761 |
| 100 | Pancreatic secretion_Homo sapiens_hsa04972 | 0.84509215 |
| 101 | Sulfur relay system_Homo sapiens_hsa04122 | 0.84422291 |
| 102 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.81825069 |
| 103 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.81314175 |
| 104 | Hypertrophic cardiomyopathy (HCM)_Homo sapiens_hsa05410 | 0.78746892 |
| 105 | Arrhythmogenic right ventricular cardiomyopathy (ARVC)_Homo sapiens_hsa05412 | 0.77918251 |
| 106 | Proteasome_Homo sapiens_hsa03050 | 0.77766893 |
| 107 | Oocyte meiosis_Homo sapiens_hsa04114 | 0.76266407 |
| 108 | Tight junction_Homo sapiens_hsa04530 | 0.73058474 |
| 109 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.72998696 |
| 110 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.72588955 |
| 111 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.72084051 |
| 112 | * AMPK signaling pathway_Homo sapiens_hsa04152 | 0.71910925 |
| 113 | Glioma_Homo sapiens_hsa05214 | 0.71081348 |
| 114 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.70581212 |
| 115 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.70086386 |
| 116 | Steroid biosynthesis_Homo sapiens_hsa00100 | 0.68288728 |
| 117 | Phototransduction_Homo sapiens_hsa04744 | 0.67753702 |
| 118 | Olfactory transduction_Homo sapiens_hsa04740 | 0.67628658 |
| 119 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.66125600 |
| 120 | Ras signaling pathway_Homo sapiens_hsa04014 | 0.65499640 |
| 121 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 0.64649496 |
| 122 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.64552205 |
| 123 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.64241767 |
| 124 | Endocytosis_Homo sapiens_hsa04144 | 0.63486719 |
| 125 | ErbB signaling pathway_Homo sapiens_hsa04012 | 0.63274727 |
| 126 | Rap1 signaling pathway_Homo sapiens_hsa04015 | 0.61243655 |
| 127 | Hippo signaling pathway_Homo sapiens_hsa04390 | 0.59427057 |
| 128 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | 0.57133119 |
| 129 | Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | 0.55769049 |
| 130 | Metabolic pathways_Homo sapiens_hsa01100 | 0.55233409 |
| 131 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.54419612 |
| 132 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 0.54337854 |
| 133 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.54198266 |
| 134 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 0.54078632 |
| 135 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.53621783 |
| 136 | Longevity regulating pathway - multiple species_Homo sapiens_hsa04213 | 0.52001748 |
| 137 | Endometrial cancer_Homo sapiens_hsa05213 | 0.49285817 |
| 138 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | 0.49133195 |
| 139 | Adherens junction_Homo sapiens_hsa04520 | 0.48460803 |
| 140 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 0.48286995 |
| 141 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 0.47496738 |
| 142 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | 0.46426473 |
| 143 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.45679430 |
| 144 | Hedgehog signaling pathway_Homo sapiens_hsa04340 | 0.44278747 |
| 145 | Galactose metabolism_Homo sapiens_hsa00052 | 0.43822712 |
| 146 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.42813376 |
| 147 | Insulin signaling pathway_Homo sapiens_hsa04910 | 0.42757245 |
| 148 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.41020619 |
| 149 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.39455434 |
| 150 | Focal adhesion_Homo sapiens_hsa04510 | 0.39100111 |
| 151 | Legionellosis_Homo sapiens_hsa05134 | 0.38206020 |
| 152 | Regulation of autophagy_Homo sapiens_hsa04140 | 0.37866923 |
| 153 | Renin-angiotensin system_Homo sapiens_hsa04614 | 0.36143190 |
| 154 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 0.33202087 |
| 155 | Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | 0.33057458 |
| 156 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.32450893 |
| 157 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 0.31171276 |
| 158 | Lysine degradation_Homo sapiens_hsa00310 | 0.29137414 |
| 159 | Insulin resistance_Homo sapiens_hsa04931 | 0.28264401 |
| 160 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 0.28134254 |
| 161 | Pyrimidine metabolism_Homo sapiens_hsa00240 | 0.26970529 |
| 162 | Protein export_Homo sapiens_hsa03060 | 0.22302390 |
| 163 | Lysosome_Homo sapiens_hsa04142 | 0.21318865 |
| 164 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.18750473 |
| 165 | Antigen processing and presentation_Homo sapiens_hsa04612 | 0.18401422 |
| 166 | Hepatitis C_Homo sapiens_hsa05160 | 0.18139965 |
| 167 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 0.17076438 |
| 168 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 0.16548435 |
| 169 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.09508461 |
| 170 | Aminoacyl-tRNA biosynthesis_Homo sapiens_hsa00970 | 0.08161183 |
| 171 | Influenza A_Homo sapiens_hsa05164 | 0.07697800 |
| 172 | Other glycan degradation_Homo sapiens_hsa00511 | 0.07635287 |
| 173 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.06670805 |
| 174 | Measles_Homo sapiens_hsa05162 | 0.05241886 |
| 175 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 0.05014069 |
| 176 | Prion diseases_Homo sapiens_hsa05020 | 0.05002866 |
| 177 | Allograft rejection_Homo sapiens_hsa05330 | 0.04793204 |
| 178 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 0.03503286 |
| 179 | Mineral absorption_Homo sapiens_hsa04978 | 0.02462293 |
| 180 | Pertussis_Homo sapiens_hsa05133 | 0.02331137 |
| 181 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.01655675 |

